These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 9162907)

  • 1. [Effect of antithyroid medication on the effective half-life and uptake of 131-iodine following radioiodine therapy].
    Moka D; Voth E; Schicha H
    Nuklearmedizin; 1997 Apr; 36(3):87-92. PubMed ID: 9162907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radioiodine therapy of Graves' disease--a dosimetric comparison of various therapy regimens of antithyroid agents].
    Urbannek V; Voth E; Moka D; Schicha H
    Nuklearmedizin; 2001 Aug; 40(4):111-5. PubMed ID: 11556200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of factors affecting the therapeutic outcome of radioiodine therapy in patients with Graves' disease].
    Sabri O; Schulz G; Zimny M; Schreckenberger M; Zimny D; Wagenknecht G; Kaiser HJ; Dohmen BM; Bares R; Büll U
    Nuklearmedizin; 1998 May; 37(3):83-9. PubMed ID: 9604227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
    Berg GE; Michanek AM; Holmberg EC; Fink M
    J Nucl Med; 1996 Feb; 37(2):228-32. PubMed ID: 8667049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of short-term interruption of antithyroid drugs on the outcome of radioiodine therapy of Graves' disease: results of a prospective study.
    Eschmann SM; Thelen MH; Dittmann H; Bares R
    Exp Clin Endocrinol Diabetes; 2006 May; 114(5):222-6. PubMed ID: 16804795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioiodine therapy of benign thyroid disorders: what are the effective thyroidal half-life and uptake of 131I?
    Kobe C; Eschner W; Wild M; Rahlff I; Sudbrock F; Schmidt M; Dietlein M; Schicha H
    Nucl Med Commun; 2010 Mar; 31(3):201-5. PubMed ID: 19907353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of additional inactive iodide during radioiodine therapy for Graves' disease: who might benefit?
    Dietlein M; Moka D; Reinholz U; Schmidt M; Schomäcker K; Schicha H; Wellner U
    Nuklearmedizin; 2007; 46(3):77-84. PubMed ID: 17549318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
    Czarnywojtek A; Czepczynski R; Ruchala M; Wasko R; Zgorzalewicz-Stachowiak M; Szczepanek E; Zamyslowska H; Bartkowiak Z; Florek E; Sowinski J
    Neuro Endocrinol Lett; 2009; 30(2):209-14. PubMed ID: 19675515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcome.
    Walter MA; Christ-Crain M; Eckard B; Schindler C; Nitzsche EU; Müller-Brand J; Müller B
    Eur J Clin Invest; 2004 May; 34(5):365-70. PubMed ID: 15147334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioiodine therapy and thyrostatic drugs and iodine.
    Moka D; Dietlein M; Schicha H
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S486-91. PubMed ID: 12192550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graves' disease and radioiodine therapy. Is success of ablation dependent on the choice of thyreostatic medication?
    Kobe C; Weber I; Eschner W; Sudbrock F; Schmidt M; Dietlein M; Schicha H
    Nuklearmedizin; 2008; 47(4):153-6. PubMed ID: 18690374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the long-term efficacy of low dose 131I versus antithyroid drugs in the treatment of hyperthyroidism.
    Chen DY; Jing J; Schneider PF; Chen TH
    Nucl Med Commun; 2009 Feb; 30(2):160-8. PubMed ID: 19194213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of iodine application during radioiodine therapy in patients with impending therapy failure].
    Urbannek V; Schmidt M; Moka D; Hillger HW; Voth E; Wellner U; Schicha H
    Nuklearmedizin; 2000; 39(4):108-12. PubMed ID: 10919161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
    Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
    Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of diffuse hyperthyroid goiter with radioiodine: influence of propylthiouracil pretreatment].
    Véliz J; Pineda G; Arancibia P; Wohllk N
    Rev Med Chil; 2000 Jun; 128(6):609-12. PubMed ID: 11016059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characterization of therapy failures in radioiodine therapy of Graves' disease without simultaneous antithyroid agents].
    Sabri O; Zimny M; Schreckenberger M; Reinartz P; Nowak B; Ostwald E; Schäfer W; Block S; Setani K; Büll U
    Nuklearmedizin; 2001 Feb; 40(1):1-6. PubMed ID: 11373933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iodine prophylaxis intensification. Influence on radioiodine uptake and activity of 131I used in the treatment of hyperthyroid patients with Graves' disease.
    Baczyk M; Junik R; Ziemnicka K; Sowiński J
    Nuklearmedizin; 2005; 44(5):197-9. PubMed ID: 16395495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of carbimazole following radioiodine therapy on radiation dose to the thyroid.
    Gimlette TM; Kocak R; Herbert RG; Squire CR
    Nuklearmedizin; 1981 Apr; 20(2):72-5. PubMed ID: 6165965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follow-up on thyroidal uptake after radioiodine therapy: how robust is the peri-therapeutic dosimetry?
    Eschner W; Kobe C; Schicha H
    Z Med Phys; 2011 Dec; 21(4):258-65. PubMed ID: 21719262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithyroid drug regimens before and after 131I-therapy for hyperthyroidism: evidence-based?
    Mijnhout GS; Franken AA
    Neth J Med; 2008 Jun; 66(6):238-41. PubMed ID: 18689906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.